ACCO Brands Earnings Call Transcripts
Fiscal Year 2026
-
First quarter sales and adjusted EPS exceeded expectations, driven by the EPOS acquisition, strong performance in technology peripherals, and positive FX. Full-year guidance was reiterated, with cost savings and growth initiatives offsetting anticipated cost pressures from global uncertainties.
Fiscal Year 2025
-
2025 results met expectations despite global and tariff challenges, with strong execution in technology peripherals and cost savings. The EPOS acquisition and operational improvements are set to drive revenue and margin growth in 2026, with improved cash flow and leverage expected.
-
Q3 sales declined 9% year-over-year, but gross margin improved and adjusted EPS met guidance. Cost savings and pricing actions are expected to drive improved Q4 results, with Technology Accessories and Gaming Accessories leading growth.
-
Second-quarter sales and adjusted EPS met expectations, with cost savings and pricing actions helping offset tariff impacts. Full-year sales are expected to decline 7–8.5%, but margin improvement and cash flow generation are anticipated in the second half.
-
First quarter sales met expectations, with adjusted EPS above outlook and gross margin up 60 bps, driven by cost savings and favorable mix. Ongoing tariff uncertainty is impacting demand and guidance, but supply chain shifts and price actions are underway.
Fiscal Year 2024
-
Full-year 2024 results met expectations, with strong free cash flow and reduced net debt despite FX headwinds. Cost savings programs expanded, margins improved, and 2025 guidance anticipates sales declines but better trends as the year progresses.
-
Q3 2024 results met expectations with improved revenue trends and margin expansion, driven by cost reductions and growth in technology accessories. Balance sheet strengthened through debt reduction and refinancing, while the muted demand environment and conservative retailer inventory practices continue to impact sales.
-
Adjusted EPS and gross margin exceeded expectations despite an 11% sales decline, driven by cost reductions and improved product mix. Inventory and leverage improved, with a $165M impairment charge and a focus on balanced capital allocation and tuck-in M&A.